Status:
COMPLETED
The Ability of Octenilin® to Reduce Odour of Malodorous Wound
Lead Sponsor:
School of Health Sciences Geneva
Conditions:
Wound
Wound Heal
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Malodours are a common complication of chronic wounds. They are the result of the proliferation of aerobic and anaerobic micro-organisms on the wound surface, where they metabolize healthy tissue whic...
Detailed Description
Malodours are a common complication of chronic wounds. They are the result of the proliferation of aerobic and anaerobic micro-organisms on the wound surface, where they metabolize healthy tissue whic...
Eligibility Criteria
Inclusion
- A chronic malodourous wound
- Age over 18 years
- Proficiency in the French language
Exclusion
- Valid informed consent is not or cannot be given
- Patients needing dressings with Silver
- Patients needing charcoal dressings
- Patients under antibiotic treatment
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 22 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04669626
Start Date
July 1 2020
End Date
December 22 2021
Last Update
May 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cité Génération Maison de santé
Onex, Canton of Geneva, Switzerland, 1213